Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 27-01-2015 | Practice Area: | Equity Capital Markets |
| Deal Title: | Keryx Biopharmaceuticals Offering of Common Stock | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised J.P. Morgan Securities LLC as sole book-running manager and representative of the underwriters of a USD119 million SEC-registered offering of 9,166,667 shares of common stock of Keryx Biopharmaceuticals, Inc., including 1,375,000 shares from the exercise of the underwriters' option. Keryx's common stock is listed on The NASDAQ Global Select Market under the symbol "KERX".
The Davis Polk corporate team included partner Richard D. Truesdell Jr. and associates Jeannette K. Safi and Jennifer Ying Lan.
|
||
| Financial Center: | New York | Value: | 100.01-500.00 |
| Advised Party: | Underwriter | Law Firm | Davis Polk |
| Issuer Jurisdiction - | United States | Listing Jurisdiction - | United States |
| Classification: |
Secondary Offerings and Placings NASDAQ: |
Lawyer | Richard D Truesdell Jr |
